Ohm Pituitarum Complex Liquid
NDC Package 66096-122-05
Package Information
Ohm Pituitarum Complex (adrenal gland, adrenocorticotrophin, cerebrum, liver gland, pituitarum posterium gland, placenta, thyroidinum.) liquids is classified as a
- adrenergic alpha-agonists - [moa] (mechanism of action)
- adrenergic beta-agonists - [moa] (mechanism of action)
- adrenocorticotropic hormone - [cs]
- adrenocorticotropic hormone - [epc] (established pharmacologic class)
- catecholamine - [epc] (established pharmacologic class)
- catecholamines - [cs]
- alpha-adrenergic agonist - [epc] (established pharmacologic class)
- beta-adrenergic agonist - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Adrenocorticotropic Hormone - [CS]
- Adrenocorticotropic Hormone - [EPC] (Established Pharmacologic Class)
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 66096 - Ohm Pharma Inc.
- 66096-122 - Ohm Pituitarum Complex
- 66096-122-05 - 59 mL in 1 BOTTLE, SPRAY
- 66096-122 - Ohm Pituitarum Complex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66096-122-05 identifies a specific commercial package of 59 ml in 1 bottle, spray of Ohm Pituitarum Complex, a human prescription drug labeled by Ohm Pharma Inc.. This liquid is formulated for oral use and contains corticotropin; epinephrine; sus scrofa adrenal gland; sus scrofa cerebrum; sus scrofa pituitary gland, posterior; sus scrofa placenta; thyroid, unspecified as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on April 10, 2017. The current certification is valid through December 31, 2026.
How is this Ohm Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096012205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.